Clinical Trial

Clinical Study on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of PPSV23

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated April 4, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The research objective is to evaluate lot-to-lot consistency and immune persistence of three commercial batches of 23 valent pneumococcal polysaccharide vaccine.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-11.
Trial Details
NCT Number NCT06314867
Lead Sponsor Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Conditions Healthy Volunteers
Enrollment 990 participants
Start Date 2023-01-30
Primary Completion 2024-12-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-04-04